• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《“腹水 中 MFAP4 水平 独立 预测 肝硬化 患者 1 年 无移植 生存率”的 勘误》[《肝脏病学报告》3 (2021) 100287]

Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287].

作者信息

Torp Nikolaj, Israelsen Mads, Madsen Bjørn, Lutz Philipp, Jansen Christian, Strassburg Christian, Mortensen Christian, Knudsen Anne Wilkens, Sorensen Grith Lykke, Holmskov Uffe, Schlosser Anders, Thiele Maja, Trebicka Jonel, Krag Aleksander

机构信息

Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.

Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

出版信息

JHEP Rep. 2021 Aug 27;3(5):100353. doi: 10.1016/j.jhepr.2021.100353. eCollection 2021 Oct.

DOI:10.1016/j.jhepr.2021.100353
PMID:34693237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8514409/
Abstract

[This corrects the article DOI: 10.1016/j.jhepr.2021.100287.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.jhepr.2021.100287。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec86/8514409/5ec151812f4c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec86/8514409/5ec151812f4c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec86/8514409/5ec151812f4c/ga1.jpg

相似文献

1
Corrigendum to 'Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis' [JHEP Reports 3 (2021) 100287].《“腹水 中 MFAP4 水平 独立 预测 肝硬化 患者 1 年 无移植 生存率”的 勘误》[《肝脏病学报告》3 (2021) 100287]
JHEP Rep. 2021 Aug 27;3(5):100353. doi: 10.1016/j.jhepr.2021.100353. eCollection 2021 Oct.
2
Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.腹水样本中MFAP4的水平可独立预测肝硬化患者1年无移植生存率。
JHEP Rep. 2021 Mar 29;3(3):100287. doi: 10.1016/j.jhepr.2021.100287. eCollection 2021 Jun.
3
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.Emricasan 预防 NASH 相关失代偿性肝硬化患者的新失代偿。
J Hepatol. 2021 Feb;74(2):274-282. doi: 10.1016/j.jhep.2020.09.029. Epub 2020 Oct 8.
4
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
5
Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.复发性及治疗无反应性自发性细菌性腹膜炎会恶化失代偿期肝硬化患者的生存状况。
J Clin Exp Hepatol. 2021 May-Jun;11(3):334-342. doi: 10.1016/j.jceh.2020.08.010. Epub 2020 Sep 6.
6
Risk stratification of decompensated cirrhosis patients by Chronic Liver Failure Consortium scores: Classification and regression tree analysis.慢性肝衰竭联盟评分对失代偿期肝硬化患者的风险分层：分类与回归树分析
Hepatol Res. 2017 Mar;47(4):328-337. doi: 10.1111/hepr.12751. Epub 2016 Jul 18.
7
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure.CLIF 联盟急性失代偿评分（CLIF-C ADs）用于预测无慢加急性肝衰竭的住院肝硬化患者的预后。
J Hepatol. 2015 Apr;62(4):831-40. doi: 10.1016/j.jhep.2014.11.012. Epub 2014 Nov 22.
8
Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis.慢性肝衰竭联盟评分与传统模型对肝硬化患者死亡率预测的预后价值比较。
Gastroenterol Hepatol. 2017 Apr;40(4):276-285. doi: 10.1016/j.gastrohep.2017.01.001. Epub 2017 Feb 20.
9
CLIF-SOFA scoring system accurately predicts short-term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis.CLIF-SOFA评分系统能准确预测酒精性肝硬化急性失代偿患者的短期死亡率：一项回顾性分析
Liver Int. 2015 Jan;35(1):46-57. doi: 10.1111/liv.12683. Epub 2014 Oct 1.
10
MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.MELD-GRAIL-Na：肝移植等待名单上的肾小球滤过率和死亡率。
Hepatology. 2020 May;71(5):1766-1774. doi: 10.1002/hep.30932. Epub 2020 Jan 29.

本文引用的文献

1
Prediction of liver fibrosis severity in alcoholic liver disease by human microfibrillar-associated protein 4.人微原纤维相关蛋白4对酒精性肝病肝纤维化严重程度的预测
Liver Int. 2020 Jul;40(7):1701-1712. doi: 10.1111/liv.14491. Epub 2020 May 10.
2
Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients.经活检证实的酒精性肝病的死亡率：一项基于全国人群的队列研究，涉及3453例患者。
Gut. 2021 Jan;70(1):170-179. doi: 10.1136/gutjnl-2019-320446. Epub 2020 Mar 27.
3
Transcriptional Dynamics of Hepatic Sinusoid-Associated Cells After Liver Injury.
肝损伤后肝窦相关细胞的转录动力学。
Hepatology. 2020 Dec;72(6):2119-2133. doi: 10.1002/hep.31215. Epub 2020 Oct 20.
4
Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.持续低 MELD-Na 评分的患者仍存在肝脏相关死亡风险。
Transplantation. 2020 Jul;104(7):1413-1418. doi: 10.1097/TP.0000000000002997.
5
Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival.失代偿期肝硬化和慢加急性肝衰竭中存在混合纤溶表型，且伴有并发症和生存不良者存在低纤溶。
Hepatology. 2020 Apr;71(4):1381-1390. doi: 10.1002/hep.30915. Epub 2019 Oct 24.
6
Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis.在一组274例肝硬化患者中，腹水总蛋白水平低与自发性细菌性腹膜炎的发生无关。
Scand J Gastroenterol. 2018 Feb;53(2):200-205. doi: 10.1080/00365521.2017.1411973. Epub 2017 Dec 7.
7
Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients.评估生物标志物候选物MFAP4用于丙型肝炎患者肝纤维化的无创评估。
J Transl Med. 2016 Jul 4;14(1):201. doi: 10.1186/s12967-016-0952-3.
8
Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites.腹腔穿刺术对晚期肝硬化腹水患者代谢活性的影响。
Scand J Gastroenterol. 2016;51(5):601-9. doi: 10.3109/00365521.2015.1124282. Epub 2015 Dec 16.
9
Characterization of Microfibrillar-associated Protein 4 (MFAP4) as a Tropoelastin- and Fibrillin-binding Protein Involved in Elastic Fiber Formation.微原纤维相关蛋白4（MFAP4）作为参与弹性纤维形成的原弹性蛋白和原纤维蛋白结合蛋白的特性分析
J Biol Chem. 2016 Jan 15;291(3):1103-14. doi: 10.1074/jbc.M115.681775. Epub 2015 Nov 24.
10
Microfibrillar-Associated Protein 4: A Potential Biomarker for Screening for Liver Fibrosis in a Mixed Patient Cohort.微原纤维相关蛋白4：混合患者队列中肝纤维化筛查的潜在生物标志物。
PLoS One. 2015 Oct 13;10(10):e0140418. doi: 10.1371/journal.pone.0140418. eCollection 2015.